← All organizations

InSightec

For profit

Also known as: InSightec

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jul 30, 2024

Timeline

1990s

Jul 1, 1999
InSightec— Founded

Drugs by trial phase (4 distinct, 7 trials)

Phase 3 (1 own, 0 via acquisition)

pembrolizumab

Phase 2 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

aducanumab

Indications

Studied for

Glioblastoma

Recent trials (7)

NCT05879120CollaboratorPhase 2Jul 30, 2024
NCT05630209Lead sponsorPhase 1/Phase 2Dec 31, 2022
NCT05615623Lead sponsorPhase 1/Phase 2Dec 10, 2022
NCT05317858Lead sponsorPhase 3Aug 12, 2022
NCT05469009CollaboratorEarly Phase 1Jul 14, 2022
NCT04440358Lead sponsorPhase 1/Phase 2Oct 13, 2020
NCT04417088Lead sponsorPhase 1/Phase 2Jun 30, 2020

Details

Founded: Tirat Carmel, IL Jul 1, 1999
Last known activity: Jul 30, 2024